BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• BioMidwest

  Medtronic, Inc., Abbott Laboratories Awarded First Ever Sharedclarity Contracts

  March 3, 2014

   · 

  1 min read
• Drug Development

  S1 BioPharma (Formerly Known As S1 Pharmaceuticals, Inc.) Prepares To Initiate Phase 2a Clinical Trial For Low Male Sexual Desire

  March 3, 2014

   · 

  3 min read
• Deals

  Durham’s SCYNEXIS, Inc. Files For $55 Million IPO

  March 3, 2014

   · 

  1 min read
• BioMidwest

  Medline Industries, Inc. Guidewires Recalled Over Serious Coating Problems

  March 3, 2014

   · 

  1 min read
• FDA

  AstraZeneca PLC Wins FDA Approval For Bydureon® Pen

  March 3, 2014

   · 

  13 min read
• Drug Development

  Biocryst Pharmaceuticals Presents BCX4161 Phase 1 Trial And Kallikrein Inhibition Assay Results

  March 3, 2014

   · 

  1 min read
• Drug Development

  Cell Therapeutics, Inc. Opens Enrollment For PERSIST-2 Phase 3 Trial Of Pacritinib For Patients With Myelofibrosis Who Have Low Platelet Counts

  March 3, 2014

   · 

  7 min read
• Bio NC

  Rho Offers Tips For Decreasing Missing Data In Analgesia Clinical Trials

  March 3, 2014

   · 

  4 min read
• Deals

  Shyndec Pays $49 Million For 30% Of Rongsheng Pharma

  March 3, 2014

   · 

  1 min read
• Drug Development

  Pfizer Inc. Revs Up For Testing Of Over-The-Counter Lipitor

  March 3, 2014

   · 

  1 min read